Literature DB >> 11370574

Ischemic optic neuropathies.

A C Arnold1.   

Abstract

Ischemia of the optic nerve may occur in several forms, usually associated with vasculopathic risk factors or vasculitis, and may present with various patterns of optic disc appearance and dysfunction. Though a proven therapy is not available for the most common syndromes, correct identification may present severe visual loss or systemic complications in some cases.

Entities:  

Mesh：

Year:  2001        PMID： 11370574

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN： 0896-1549


  7 in total

1.  The role of mitochondria in health, ageing, and diseases affecting vision.

Authors:  A A Sadun; V Carelli
Journal:  Br J Ophthalmol       Date:  2006-07       Impact factor: 4.638

Review 2.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

Review 3.  The optic nerve head in acquired optic neuropathies.

Authors:  Evelyn C O'Neill; Helen V Danesh-Meyer; Paul P Connell; Ian A Trounce; Michael A Coote; David A Mackey; Jonathan G Crowston
Journal:  Nat Rev Neurol       Date:  2010-03-09       Impact factor: 42.937

Review 4.  Ischemic optic neuropathies and their models: disease comparisons, model strengths and weaknesses.

Authors:  Steven L Bernstein; Neil R Miller
Journal:  Jpn J Ophthalmol       Date:  2015-02-18       Impact factor: 2.447

5.  Amiodarone induced optic neuropathy.

Authors:  P K Nagra; R Foroozan; P J Savino; I Castillo; R C Sergott
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

Review 6.  A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis.

Authors:  Michel Toledano; Brian G Weinshenker; Andrew J Solomon
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 6.030

Review 7.  Ocular vasculitis.

Authors:  J Banks Shepherd
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.